Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors

NCT05751837 is registered in ClinicalTrials.gov with Patrick Wagner, MD, FACS as lead sponsor.

NCT NCT05751837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05751837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors
Lead sponsor
Patrick Wagner, MD, FACS
Phase
Phase 1
Overall status
Completed
Start date
March 16, 2023
Completion date
May 30, 2024
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, malignancy